Integration of ligand and structure-based pharmacophore screening for the identification of novel natural leads against Euchromatic histone lysine methyltransferase 2 (EHMT2/G9a)

Abhisek Janaa Department of Chemistry, National Institute of Technology Durgapur, Durgapur, IndiaView further author information

Rahul Nagab Department of Biotechnology, National Institute of Technology Durgapur, Durgapur, IndiaView further author information

Sougata Sahab Department of Biotechnology, National Institute of Technology Durgapur, Durgapur, IndiaView further author information

Christian Griñán-Ferréc Department of Pharmacology and Therapeutic Chemistry, Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain;d Centro de Investigación en Red, Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain

https://orcid.org/0000-0002-5424-9130 View further author information

Deb Ranjan Banerjeea Department of Chemistry, National Institute of Technology Durgapur, Durgapur, IndiaCorrespondence[email protected]

https://orcid.org/0000-0002-2058-896X View further author information

Citations (0)

Keep up to date with the latest research on this topic with citation updates for this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Integration of ligand and structure-based pharmacophore screening for the identification of novel natural leads against Euchromatic histone lysine methyltransferase 2 (EHMT2/G9a)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Integration of ligand and structure-based pharmacophore screening for the identification of novel natural leads against Euchromatic histone lysine methyltransferase 2 (EHMT2/G9a)

Citations (0)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date